Strengthen Stirling Refrigeration Technology

In order to continue to enhance the Stirling refrigeration technology barriers, and to achieve independent control of core components, expand the business layout of the cryogenic field, Haier Biomedical released an announcement on the evening of June 7, the company intends to use its own funds of $6 million USD in the form of installment payments to participate in the Shanghai ChaoLian Technology company to increase capital. Shanghai ChaoLian Technology Co., Ltd. is a leading global provider of Stirling refrigeration solutions. After the completion of the capital increase, Haier Biomedical shareholding ratio increased from 15% to 54.31%.

The acquisition will further enhance Haier Biomedical’s leading position in cryogenic technology platform, solve the key problems of the core components of Stirling ultra-low temperature freezer technology, which will be further extended to new scenarios of cryogenic processing, infrared detection, hazardous chemical detection and cryogenic cold therapy in the future, providing new power for the company's long-term sustainable development in the field of cryogenics.

Stirling refrigeration technology has strong advantages in terms of safety, energy saving and stability. It uses helium as the refrigeration medium and the lowest temperature can reach below -196℃, while the refrigeration efficiency is higher, saving 50% energy and increasing 100% reliability compared to compressor refrigeration. In the context of carbon neutrality becoming an industry-wide development goal, the industrial application of Stirling refrigeration technology is an inevitable choice for the development of the refrigeration industry. In addition, the application field of the Stirling refrigeration machine is also expanding, in addition to the traditional medical, pharmaceutical, and other industries, the Stirling refrigeration machine will be a key solution for industries such as renewable energy, aerospace, military and other fields of application is also expanding, which will bring more opportunities and potential for the Stirling refrigeration machine market.

Since its establishment, the company has been committed to the industrial application of Stirling refrigeration technology in the industrial field, and its main products, Stirling refrigerators, have been used in many fields such as cryogenic storage, cryogenic processing, and infrared detection as key components. The company has a domestic first-class Stirling refrigeration research team, team members in the Stirling refrigeration technology applied to aerospace and other fields have a wealth of experience. As a national high-tech enterprise, Chaolian has completely independent intellectual property rights in the field of Stirling cryogenic refrigerator and vacuum encapsulation and has obtained 12 patents (including 4 invention patents), and its main business, Stirling refrigerator product series, will achieve batch industrialization from 2024.

Haier Biomedical began with the research, production, and sales of biomedical cryogenic storage devices, and is an ecological brand of life science and medical innovation digital scenarios based on the transformation of the Internet of Things. The company is committed to building high efficiency and high reliability of the leading ability, launched the "high-efficiency , anti-disturbance Stirling refrigerator control system and its application in ultra-low temperature refrigerators" scientific research project a few years ago, and successfully break through the high-efficiency Stirling refrigerator control technology problems, in the high-efficiency, high reliability control to reach the international leading level. Its domestic first Stirling ultra-low temperature refrigerator to achieve the traditional complex refrigeration to Stirling refrigeration leap, both more uniform refrigeration, energy saving half, safety zero downtime and other characteristics, for the deep cryogenic industry low carbon transformation and upgrading to explore a new path.

After the completion of this capital increase, the two sides will work together to build the technical barriers of Stirling refrigeration and accelerate the industrialization of Stirling refrigeration technology. By accelerating the key core technology research and industrialization application of Stirling refrigeration, we will provide users with safe and worry-free, green, and efficient scenario solutions.

The person in charge of Haier Biomedical told reporters that looking ahead, Haier Biomedical will also continue to play the role of Stirling refrigeration technology in the supply chain synergy to support ULT storage solutions, active Liquid Nitrogen Container storage solutions, Large Volume Sample Library Products and other program upgrades at the same time, to support the Controlled Rate Freezer, Freeze Dryer, Freeze-thaw Machine and other product differentiation competitiveness, and will further extend to infrared detection, hazardous chemical detection, cryogenic cold therapy and other new areas to open up new space for the company's future growth.